Sonography of the Optic Nerve Sheath Diameter for Detection of Elevated Intracranial Pressure (ICP)

NCT ID: NCT03529370

Last Updated: 2020-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2019-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the invistigators chose to measure the optic nerve sheath diameter by sonography for diagnosis of elevated intracranial pressure (ICP) in comparison to brain computed tomograhy (CT) as the reference gold standard for detection of raised ICP since optic nerve songraphy is radiation-free , noninvasive, and has certain features which increase its convenience portability, easy application, low cost, repeatability on request, bedside application, short application time and applicability even in the presence of unstable vital signs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Elevated intracranial pressure (ICP) is seen in head trauma, hydrocephalus, intracranial tumors, hepatic encephalopathy, and cerebral edema. Intractable elevated ICP can lead to death or devastating neurological damage either by reducing cerebral perfusion pressure (CPP) and causing cerebral ischemia or by compressing and causing herniation of the brainstem or other vital structures. Prompt recognition is crucial in order to intervene appropriately.

Intractable high ICP is the most common "terminal event" leading to death in neurosurgical patients. The association between the severity of intracranial hypertension and poor outcome after severe head injury is well recognized. Outcomes tend to be good in patients with normal ICP, whereas those with elevated ICP are much more likely to have an unfavorable outcome. Elevated ICP carries a mortality rate of around 20%.

The rapid recognition of elevated ICP is therefore of obvious and paramount importance so that it can be monitored and so that therapies directed at lowering ICP can be initiated. A raised ICP is measurable both clinically and quantitatively. Continuous ICP monitoring is important both for assessing the efficacy of therapeutic measures and for evaluating the evolution of brain injury.

The goal of ICP monitoring is to ensure maintenance of optimal CPP. The ICP also forms a basis for medical or surgical intervention in cases of increased ICP with agents such as 3% sodium chloride (NaCl), mannitol, or diuretics (Loop diuretics), ventriculostomy, cerebrospinal fluid (CSF) diversion, and phentobarbital coma or surgical decompression in cases of intractable ICP elevation that do not respond to conservative management.

ICP monitoring may be discontinued when the ICP remains in the normal range within 48-72 hours of withdrawal of ICP therapy or if the patient's neurological condition improves to the point where he or she is following commands.

Since many investigators have questioned invasive ICP monitoring in improving patient outcomes, the invistigators tried to find noninvasive method of ICP monitoring.

The optic nerve sheath is contiguous with the dura mater, and its contents are contiguous with the subarachnoid space. Thus, raised intracranial pressure (ICP) leads to an increase in the optic nerve sheath diameter.

A-mode sonography was first used for visualization of the optic nerve sheath; however, it was not until 1994, when Hansen et al used B-mode sonography, when the approach to measurement was standardized. Sonographic studies of cadaveric optic nerves together with the work of Hansen et al established that the greatest degree of distension of the sheath occurred 3 mm behind the optic globe. This location has become the standard measurement point.

As a technique, ocular sonography is quickly learned; Tayal et al showed that with an experienced operator, 10 scans with 3 abnormal scans should be sufficient training, whereas in new ultrasound operators, 25 may be needed. In addition to these findings, measurement of both eyes can be performed in less than 4 minutes.

the invistigators chose CT as the reference gold standard for detection of raised ICP as simple noninvasive method in critically ill patients. Raised ICP is diagnosed with CT on a daily basis in clinical practice. Treatments are initiated, hemicraniectomies are performed, and intraventricular shunts are inserted, all on the basis of raised ICP as seen on imaging.

The findings of elevated ICP in cranial CT (CCT) include:

1. changes in ventricular sizes;
2. lessening in basilar cistern sizes;
3. narrowing or eliminating in sulci;
4. transfalcine herniation; and
5. changes in the rate of grey/white matter. So in this study the invistigators chose to measure optic nerve sheath diameter by sonography for diagnosis of elevated ICP in comparison to brain CT as the reference gold standard for detection of raised ICP

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

optic nerve ultrasound

sonograhy of the optic nerve sheath diameter

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinically suspected raised ICP such as:

1. Patients with traumatic brain injury
2. Patients with intracranial tumours
3. Patients with hepatic encephalopathy
4. Cerebral edema: Due to head injury, ischemic stroke with vasogenic edema, hypoxic or ischemic encephalopathy, postoperative edema

Exclusion Criteria

* Patients with edema or trauma in the eye lid.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart Institute, Egypt

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Islam Hassan Mohamed Elsadek Abulnaga

Specialist of critical care medicine, National heart institute, Cairo, Egypt

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed H Abdallah, MD

Role: STUDY_DIRECTOR

Cairo University

Suzy F Michael, MD

Role: STUDY_DIRECTOR

Cairo University

Hassan K Nagi, MD

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National heart institute , Imbaba

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Robba C, Cardim D, Tajsic T, Pietersen J, Bulman M, Rasulo F, Bertuetti R, Donnelly J, Xiuyun L, Czosnyka Z, Cabeleira M, Smielewski P, Matta B, Bertuccio A, Czosnyka M. Non-invasive Intracranial Pressure Assessment in Brain Injured Patients Using Ultrasound-Based Methods. Acta Neurochir Suppl. 2018;126:69-73. doi: 10.1007/978-3-319-65798-1_15.

Reference Type BACKGROUND
PMID: 29492535 (View on PubMed)

Wang LJ, Chen LM, Chen Y, Bao LY, Zheng NN, Wang YZ, Xing YQ. Ultrasonography Assessments of Optic Nerve Sheath Diameter as a Noninvasive and Dynamic Method of Detecting Changes in Intracranial Pressure. JAMA Ophthalmol. 2018 Mar 1;136(3):250-256. doi: 10.1001/jamaophthalmol.2017.6560.

Reference Type BACKGROUND
PMID: 29392301 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Optic nerve sonography and ICP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.